sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Amyotrophic Lateral Sclerosis (ALS) Market - Global Size, Share, Trend Analysis, Opportunity and Forecast, 2019-2030, Segmented By Type (Sporadic ALS (SALS), Familial ALS (FALS)); By Treatment (Medication, Physical Therapy, Respiratory Therapy, Speech Therapy); By End User (Specialty Centers, Research & Academic Institutes); By Region (North America, Europe, Asia Pacific (APAC), Latin America (LATAM), Middle East and Africa (MEA))

Amyotrophic Lateral Sclerosis (ALS) Market - Global Size, Share, Trend...

Home / Categories / Chemicals and Materials
Amyotrophic Lateral Sclerosis (ALS) Market - Global Size, Share, Trend Analysis, Opportunity and Forecast, 2019-2030, Segmented By Type (Sporadic ALS (SALS), Familial ALS (FALS)); By Treatment (Medication, Physical Therapy, Respiratory Therapy, Speech Therapy); By End User (Specialty Centers, Research & Academic Institutes); By Region (North America, Europe, Asia Pacific (APAC), Latin America (LATAM), Middle East and Africa (MEA))
Amyotrophic Lateral Sclerosis (ALS) Market...
Report Code
RO3/128/1261

Publish Date
04/Nov/2024

Pages
200
PRICE
$ 1800 /-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350 /-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850 /-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
Global Amayotrophic Lateral Sclerosis (ALS) Market Size to Expand at Significant CAGR to Surpass USD 1.45 Billion by 2030
Global Amayotrophic Lateral Sclerosis (ALS) Market is thriving due to rising ALS prevalence, increased awareness, advancements in therapeutic options, and government funding in enhancing research and development efforts for more effective treatments.

Report Ocean, a leading strategic consulting, and Market research firm, in its recent study, estimated Global Amayotrophic Lateral Sclerosis (ALS) Market size by value at USD 902 million in 2023. During the forecast period between 2024 and 2030, Report Ocean expects Global Amayotrophic Lateral Sclerosis (ALS) Market size to expand at a CAGR of 7.10% reaching a value of USD 1,456 million in 2030. Global Amyotrophic Lateral Sclerosis (ALS) Market is driven by increasing incidence rates, advancements in medical research, and rising awareness about ALS. Enhanced diagnostic techniques and growing investment in biotechnology for ALS treatment contribute significantly. Additionally, governments' support and initiatives for rare disease research, along with collaborations between pharmaceutical companies and research institutions, propel market growth. The development of novel therapies and increasing clinical trials for ALS treatments further boost the growth of Global Amayotrophic Lateral Sclerosis (ALS) Market.

Opportunity - R&D initiatives for novel therapies

The growth of Global Amyotrophic Lateral Sclerosis (ALS) Market is significantly driven by increased research and development initiatives aimed at discovering novel therapies. Pharmaceutical companies and research institutions are investing heavily in R&D to develop innovative treatments, such as gene therapies, stem cell therapies, and novel drug candidates. These advancements are expected to improve patient outcomes and provide more effective treatment options, fueling market growth and offering hope for better management of ALS.

Impact of Escalating Geopolitical Tensions on Global Amayotrophic Lateral Sclerosis (ALS) Market

Escalating geopolitical tensions can significantly impact the Global Amyotrophic Lateral Sclerosis (ALS) Market. Disruptions in international trade and supply chains may lead to delays in the production and distribution of ALS medications and therapies. Increased regulatory scrutiny and trade restrictions can affect the availability of essential drugs and medical devices. Additionally, funding for ALS research may be diverted to address immediate geopolitical concerns, slowing advancements in treatment options. Fluctuations in currency exchange rates and economic instability can increase costs for healthcare providers and patients. Overall, geopolitical instability can hinder the accessibility and development of effective ALS treatments, impacting patient care and market growth.

Specialty Centers Are Major End Users of ALS Therapies

Global Amyotrophic Lateral Sclerosis (ALS) Market is comprised of specialty centers and research & academic institutes as end users. The specialty centers segment is a higher contributor to the growth of Global Amyotrophic Lateral Sclerosis (ALS) Market by end user. The segment dominates due to the specialized care and advanced treatment options provided by these centers, which cater specifically to ALS patients. These facilities offer comprehensive services, including diagnostics, multidisciplinary care, and access to clinical trials, making them the preferred choice for patients and driving their prominence in the market.

Competitive Landscape

Global Amayotrophic Lateral Sclerosis (ALS) Market is fiercely competitive, with numerous companies vying for a larger market share. Major companies in the market include Mitsubishi Tanabe Pharma Corporation, Otsuka Pharmaceutical Co., Ltd, BrainStorm Therapeutics, Biogen Inc., Corestem, AB Science, F. Hoffmann-La Roche AG, Biohaven Pharmaceutical, Sun Pharmaceutical, and Ionis Pharmaceuticals, Inc. These companies use various strategies, including increasing investments in their R&D activities, mergers and acquisitions, joint ventures, collaborations, licensing agreements, and new product and service releases to further strengthen their position in Global Amayotrophic Lateral Sclerosis (ALS) Market.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Amayotrophic Lateral Sclerosis (ALS) Market. It also highlights the factors driving forecasts of total Market size. The report promises to provide recent technology trends in Global Amayotrophic Lateral Sclerosis (ALS) Market and industry insights to help decision-makers make sound strategic decisions. Further, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com